Status:
COMPLETED
Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The incidence of Thyroid Cancer (TC) has increased over the last thirty years, in France and worldwide. This increase is mainly due to good prognosis microPapillary TC (mPTC). Sixty percent of diagnos...
Eligibility Criteria
Inclusion
- all patients with a good prognosis of the TC
- diagnosed in 2014
- whose medical file discussed in MultiDisciplinary Team Meeting (MDTM) in Midi-Pyrenees
Exclusion
- patients whose surgical management was carried out outside Midi Pyrenees are excluded and other morphological types are excluded (medullar, anaplastic, lymphomas, sarcomas)
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
361 Patients enrolled
Trial Details
Trial ID
NCT03787121
Start Date
April 1 2019
End Date
December 31 2020
Last Update
August 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University HospitalToulouse
Toulouse, France